Oliver Sartor

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.418Author DataRank

Indexed papers

6in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 6 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Comprehensive Analysis of Multiple Cohort Datasets Deciphers the Utility of Germline Single-Nucleotide Polymorphisms in Prostate Cancer Diagnosis

Cancer Prevention Research(2021)10.1158/1940-6207.capr-20-0534

Top 44%

0.418DataRank

Top 44%6 citations

Yan Dong, Oliver Sartor, Kun Zhang, Wensheng Zhang

Papers

Driven by 40 papers — median percentile 0. Top paper: “Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry”.

Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry

Prostate Cancer and Prostatic Diseases(2020)10.1038/s41391-020-0213-7

N/A

4.8DataRank · unranked

145 citations

Andrew J. Armstrong, Chiledum Ahaghotu, David G. McLeod, Matthew R. Cooperberg, David F. Penson +17 more

177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial

The Lancet(2024)10.1016/s0140-6736(24)01653-2

N/A

4.3DataRank · unranked

287 citations

Daniel Castellano, Ken Herrmann, Johann S. De Bono, Neal D. Shore, Kim N. +18 more

Prostate-Specific Membrane Antigen–Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591

Journal of Clinical Oncology(2023)10.1200/jco.23.00573

N/A

2.6DataRank · unranked

69 citations

Charlene Thomas, Oliver Sartor, Michael Sun, Judith Stangl‐Kremser, Mahelia Bissassar +10 more

Adjuvant docetaxel for high-risk localized prostate cancer: Update of NRG Oncology/RTOG 0521.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.333

N/A

1.0DataRank · unranked

11 citations

Theodore Karrison, Oliver Sartor, Leonard G. Gomella, Mahul B. Amin, James A. Purdy +15 more

Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going

Cancer Treatment Reviews(2024)10.1016/j.ctrv.2024.102748

N/A

0.891DataRank · unranked

28 citations

Charles L. Loprinzi, Jacob J. Orme, Regina M. Koch, Ahmed Mahmoud, Adam M. Kase +11 more

Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy

Oncotarget(2014)10.18632/oncotarget.1802

N/A

0.792DataRank · unranked

195 citations

Yanfeng Qi, Guanyi Zhang, Duo Xu, Yang Zhan, Xavier Alvarez +7 more

Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform

The Oncologist(2021)10.1002/onco.13869

N/A

0.745DataRank · unranked

16 citations

Andrew W. Hahn, Roberto Nussenzveig, Sergiusz Wesołowski, Nicolas Sayegh, Benjamin L. Maughan +11 more

Advantages of a Truly Open-Access Data-Sharing Model

New England Journal of Medicine(2017)10.1056/nejmsb1702054

N/A

0.685DataRank · unranked

95 citations

Oliver Sartor, Bruce A. Chabner, Mace L. Rothenberg, Sean Khozin, Charles Hugh-Jones +3 more

Final overall survival and safety analyses of the phase III PSMAfore trial of [177Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer

Annals of Oncology(2025)10.1016/j.annonc.2025.07.003

N/A

0.663DataRank · unranked

31 citations

K.N. Chi, Neal D. Shore, Ken Herrmann, Johann S. De Bono, Daniel Castellano +88 more

Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4476

N/A

0.631DataRank · unranked

66 citations

Wei Fu, Hao Wang, Jong C. Park, Theodore L. DeWeese, Phuoc T. Tran +14 more

Phase I study of 225Ac-J591 for men with metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5015

N/A

0.515DataRank · unranked

30 citations

Michael Sun, Oliver Sartor, Charlene Thomas, Sharon Singh, Mahelia Bissassar +11 more

Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1

JU Open Plus(2024)10.1097/ju9.0000000000000137

N/A

0.457DataRank · unranked

8 citations

Alan H. Bryce, Maha Hussain, Neeraj Agarwal, Himisha Beltran, Matthew R. Cooperberg +33 more

Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer

European Urology Oncology(2023)10.1016/j.euo.2023.11.014

N/A

0.442DataRank · unranked

18 citations

Fadi Taza, Navonil De Sarkar, Alok K. Tewari, Syed Arsalan Ahmed Naqvi, Irbaz Bin Riaz +32 more

Comprehensive Analysis of Multiple Cohort Datasets Deciphers the Utility of Germline Single-Nucleotide Polymorphisms in Prostate Cancer Diagnosis

Cancer Prevention Research(2021)10.1158/1940-6207.capr-20-0534

Top 44%

0.418DataRank

Top 44%6 citations

Yan Dong, Oliver Sartor, Kun Zhang, Wensheng Zhang

BATF-dependent Th17 cells act through the IL-23R pathway to promote prostate adenocarcinoma initiation and progression

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae120

N/A

0.373DataRank · unranked

11 citations

Seleste L Rivero, Bing Zhang, Keyi Shen, Zixuan Li, Tianhua Niu +8 more

Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR)

EClinicalMedicine(2020)10.1016/j.eclinm.2020.100693

N/A

0.312DataRank · unranked

7 citations

Shamia Hoque, Nancy F. Olivieri, Matthew A. Taylor, David M. Aboulafia, Courtney Lubaczewski +29 more

The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2022.05.048

N/A

0.252DataRank · unranked

4 citations

Theodore Karrison, Seth A. Rosenthal, Mahul B. Amin, Leonard G. Gomella, James A. Purdy +15 more

Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial

European Urology Oncology(2025)10.1016/j.euo.2025.04.009

N/A

0.214DataRank · unranked

3 citations

James A. Proudfoot, Elai Davicioni, Yang Liu, Daniel E. Spratt, Jeffry Simko +17 more

Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2

JU Open Plus(2024)10.1097/ju9.0000000000000138

N/A

0.208DataRank · unranked

3 citations

E. David Crawford, Neeraj Agarwal, Maha Hussain, Himisha Beltran, Matthew R. Cooperberg +33 more

Multivariable models of outcomes with [177Lu]Lu-PSMA-617: analysis of the phase 3 VISION trial

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102862

N/A

0DataRank · unranked

26 citations

Andrei Gafita, Johann S. De Bono, Oliver Sartor, Kim N., Bernd J. Krause +11 more

Pan-Cancer Interrogation of B7-H3 ( CD276 ) as an Actionable Therapeutic Target Across Human Malignancies

Cancer Research Communications(2024)10.1158/2767-9764.crc-23-0546

N/A

0DataRank · unranked

23 citations

John R. Lozada, Nicholas A. Zorko, Andrew Elliott, Allison Makovec, Milan Radovich +18 more

Final results of a phase I/II dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.5074

N/A

0DataRank · unranked

5 citations

Charlene Thomas, Jones T. Nauseef, Oliver Sartor, Michael Philip Sun, Sandra Huicochea Castellanos +14 more

Heterogeneity of the Treatment Effect with PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: A Living Interactive Systematic Review and Meta-analysis

European Urology(2025)10.1016/j.eururo.2024.12.007

N/A

0DataRank · unranked

36 citations

Irbaz Bin Riaz, Arifa Bibi, Muhammad Ali Khan, Manal Imran, Kaneez Zahra Rubab Khakwani +16 more

Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic Subtypes

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3471

N/A

0DataRank · unranked

11 citations

Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, Sharon Wu, Jason J. Kwon, Eamon Toye +18 more

Olanzapine for Managing Side Effects From Antiangiogenic Tyrosine-Kinase Inhibitors

Journal of Pain and Symptom Management(2025)10.1016/j.jpainsymman.2025.04.016

N/A

0DataRank · unranked

2 citations

Miguel Muniz, Candy S Peskey, Aminah Jatoi, Kathryn J. Ruddy, Jacob J. Orme +14 more

Systemic treatment options for metastatic castration resistant prostate cancer: A living systematic review

medRxiv(2025)10.1101/2025.04.15.25325837

N/A

0DataRank · unranked

0 citations

Muhammad Umair Anjum, Arifa Bibi, Muhammad Ali Khan, Kaneez Zahra Rubab Khakwani, Huan He +19 more

Cabozantinib in Chemotherapy-Pretreated Metastatic Castration-Resistant Prostate Cancer: Results of a Phase II Nonrandomized Expansion Study

UNC Libraries(2020)10.17615/yxdm-6w50

N/A

0DataRank · unranked

0 citations

Christopher J. Sweeney, Frauke Schimmöller, Dana E. Rathkopf, Naomi B. Haas, Celestia S. Higano +16 more

PARP Inhibitors and Prostate Cancer: To Infinity and BeyondBRCA

The Oncologist(2020)10.1634/theoncologist.2020-0697

N/A

0DataRank · unranked

97 citations

Cindy H. Chau, Douglas K. Price, Oliver Sartor, William D. Figg, Emily N. Risdon

A Novel Controlled PTEN-Knockout Mouse Model for Prostate Cancer Study

Frontiers in Molecular Biosciences(2021)10.3389/fmolb.2021.696537

N/A

0DataRank · unranked

15 citations

Bing Zhang, Brian G. Rowan, S. Michal Jazwinski, Asim B. Abdel‐Mageed, Chad Steele +5 more

Differential responses to taxanes and PARP inhibitors (PARPi) in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer (mCRPC) patients (pts).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5040

N/A

0DataRank · unranked

0 citations

Emily Nizialek, Jacob E. Berchuck, Panagiotis J. Vlachostergios, Ryan Ashkar, Alexandra Sokolova +14 more

The Value of Phenotypic Precision Medicine in Prostate Cancer

The Oncologist(2022)10.1093/oncolo/oyac198

N/A

0DataRank · unranked

10 citations

Amanda J. Broderick, Daniel J. George, Oliver Sartor, Andrew J. Armstrong, Nathan Hawkey

Quantitative assessment of PSMA imaging before and after 177Lu-PSMA-617 treatment in a Ph I/II trial.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.037

N/A

0DataRank · unranked

2 citations

Charlene Thomas, Michael Sun, Oliver Sartor, Sharon Singh, Mahelia Bissassar +15 more

Assessment of patient-reported outcomes (PROs) and longer-term adverse events (AEs) in phase I study of 225Ac-J591-PSMA for metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.077

N/A

0DataRank · unranked

2 citations

Charlene Thomas, Benedict Ho, Juana Martinez Zuloaga, Brian D. Gonzalez, Michael Sun +15 more

Basal-luminal subtyping of localized high-risk prostate cancer and benefit of adding docetaxel to definitive radiotherapy with androgen suppression in the NRG Oncology/RTOG 0521 phase III trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5094

N/A

0DataRank · unranked

3 citations

James A. Proudfoot, Elai Davicioni, Yang Liu, Daniel E. Spratt, Felix Y. Feng +15 more

Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse survival in AR -altered lethal prostate cancer

medRxiv(2023)10.1101/2023.12.01.23299215

N/A

0DataRank · unranked

1 citations

Irfan Alahi, Savar Sinha, Alexander L. Shiang, Ryan Mueller, Jace Webster +18 more

Data from Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

(2023)10.1158/1078-0432.c.6530555

Top 100%

0DataRank

Top 100%0 citations

Wei Fu, Hao Wang, Jong C. Park, Theodore L. DeWeese, Phuoc T. Tran +14 more

Data from Comprehensive Analysis of Multiple Cohort Datasets Deciphers the Utility of Germline Single-Nucleotide Polymorphisms in Prostate Cancer Diagnosis

(2023)10.1158/1940-6207.c.6547363.v1

Top 100%

0DataRank

Top 100%0 citations

Yan Dong, Oliver Sartor, Kun Zhang, Wensheng Zhang

Supplementary Data from Comprehensive Analysis of Multiple Cohort Datasets Deciphers the Utility of Germline Single-Nucleotide Polymorphisms in Prostate Cancer Diagnosis

INDIGO (University of Illinois at Chicago)(2023)10.1158/1940-6207.22534051.v1

Top 100%

0DataRank

Top 100%0 citations

Yan Dong, Oliver Sartor, Kun Zhang, Wensheng Zhang

Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancer

Urologic Oncology Seminars and Original Investigations(2020)10.1016/j.urolonc.2020.08.003

N/A

0DataRank · unranked

41 citations

Neal D. Shore, Diane Cope, Andrea McNatty, Javid J. Moslehi, Leonard G. Gomella +2 more

SEER and Gene Expression Data Analysis Deciphers Racial Disparity Patterns in Prostate Cancer Mortality and the Public Health Implication

Scientific Reports(2020)10.1038/s41598-020-63764-4

N/A

0DataRank · unranked

19 citations

Yan Dong, Oliver Sartor, Erik K. Flemington, Kun Zhang, Wensheng Zhang

Oliver Sartor

Indexed papers

Top data-sharing exemplar

Papers